Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.


Impulse Dynamics


Sustainable and strategic product positioning in key Latin American markets (BRA, COL and MEX).

In July 2022, the new Brazilian guidelines for the diagnosis and treatment of myocarditis were published.

These guidelines take into account the current scientific evidence and now recommend the use of endomyocardial biopsies (EMB) according to a well-defined scheme (yellow marker).

i²medi Comercial Medical Ltda. in Brazil, has been working on behalf of the world's leading laboratory for differential EMB diagnosis, the IKDT (INSTITUT KARDIALE DIAGNOSTIK und THERAPIE GMBH) in Berlin, on the business development of EMBs in Brazil for over 4 years.

The inclusion of endomyocardial biopsies (EMBs) in the treatment pathway is a significant milestone in providing patients with individualized therapy to improve their clinical prognosis in the future.


Go back

Copyright 2024. All Rights Reserved.
Settings saved
You are using an outdated browser. The website may not be displayed correctly. Close